Publications based on CRC1479 funding

Ingelfinger F, Levy N, Ergen C, Bakulin A, Becker A, Boyeau P, Kim M, Ditz D, Dirks J, Maaskola J, Wertheimer T, Zeiser R, Widmer CC, Amit I, Yosef N. CytoVI: deep generative modeling of antibody-based single cell data. Nat Methods. 2026 Oct;23(10):2054-2065. doi: 10.1038/s41592-026-03224-5. Epub 2026 Sep 30.
Riemer R, Braun LM, Giesler S, Rafei-Shamsabadi D, Haferkamp S, Hartmann A, Melchinger W, Weiss M, Birth S, Philipp U, Gebhard I, Schwänen C, Hutchinson JA, Karantzelis N, Wallrabenstein T, Lowinus T, Brehm N, Rawluk J, Pfeifer D, Osswald N, Bronsert P, Rogg M, Andreev G, Boerries M, Lammer M, Nguyen VA, Schmuth M, Köhler N, Duyster J, Ihorst G, Keye P, Minguet S, Schadendorf D, Ugurel S, Thimme R, Hasselblatt P, Pearce EL, Becher B, Funke-Lorenz C, Scherer F, Bengsch B, Schell C, Placke JM, Meiss F, Apostolova P, Zeiser R. Extracorporeal photopheresis for the treatment of steroid-refractory immune related adverse events from immune checkpoint inhibitor therapy: a multi-center phase Ib/II clinical trial. Nat Commun. 2026 Oct 23;17(1):11078. doi: 10.1038/s41467-026-78897-9.

Peñarando J, Willmann D, Sum M, Jia Y, Berlin C, Braun LM, Chen Z, Urban S, Jung M, Duteil D, Metzger D, Gratzke C, Zeiser R, Greschik H, Schüle R, Metzger E. KMT9 drives T cell exclusion and dysfunction by promoting PMN-MDSCs infiltration and ARG1 expression in prostate cancer. Mol Cancer. 2026 Sep 17;25(1):223. doi: 10.1186/s12943-026-02801-8.

Hoefflin R, Greenwald AC, Galili Darnell N, Mount CW, Tiomkin Y, Gonzalez Castro LN, Wen Z, Simkin D, Patterson AB, Goliand I, Golani O, Fellus-Alyagor L, Cohen M, Joseph K, Beck J, Ravi VM, Kedmi M, Keren-Shaul H, Weller M, Addadi Y, Neidert MC, Suvà ML, Tirosh I. Spatial analysis reveals the evolving organization of IDH-mutant glioma. Cancer Cell. 2026 Sep 14;44(9):1882-1892.e7. doi: 10.1016/j.ccell.2026.08.005.
Highlighted by: Silver DJ, Xu C, Lathia JD. Scherer’s map, remapped. Cancer Cell. 2026 Sep 14;44(9):1730-1732. doi: 10.1016/j.ccell.2026.08.002.
Reuss M, Meyer T, Ingelfinger F, Hoefflin R, Jovein MM, Baniadam H, Pfeifer D, Duyster J, Duque-Afonso J, Maas-Bauer K, Wäsch R, Zebisch A, Heine A, Holderried T, Finke J, Wehr C, Zeiser R, Wertheimer T. Characterisation of TP53 mutational features and outcomes of acute myeloid leukaemia after allogeneic haematopoietic cell transplantation. Bone Marrow Transplant. 2026 Sep 4. doi: 10.1038/s41409-026-03029-2. Epub ahead of print.
Holzmüller V, Gawron J, Burk AC, Stell AV, Baur AS, Zähringer A, Fetsch V, Mäder A, Hartmann A, Talvard-Balland N, Krishna N, Cunnion K, Thienel U, Martini P, Glenn L, Ferrara JL, Al Malki MM, Choe H, Pérez-Simón JA, Schmitt-Graeff A, Buescher J, Köhler N, Mansoori Moghadam Z, Henneke P, Andrieux G, Boerries M, Zeiser R. Pegtarazimod limits acute graft-versus-host disease mortality and severity in mice and is tolerated in patients. J Clin Invest. 2026 Aug 4:e205864. doi: 10.1172/JCI205864. Epub ahead of print.
Poggio T, Gräßel L, Andrieux G, Gómez Martínez AM, Stock K, Kršić M, Gonzalez Menendez I, Kreutmair S, Orcinha C, Russ M, Yacob S, Miething C, Bonofiglio F, Montes-Mojarro IA, Köhler N, Follo M, Pfeifer D, Fend F, Quintanilla-Martinez L, Chiarle R, Voena C, Jung J, Zeiser R, Turner SD, Boerries M, Duyster J, Illert AL. CD4+ T cells orchestrate the immune response to ALK-positive T-cell lymphoma. Blood. 2026 Jul 28:blood.2026033240. doi: 10.1182/blood.2026033240. Epub ahead of print
Groß PR, Petersen S, Wang Z, Shamshiri B, de Maissin H, Lucas S, Gorka O, Heß L, Marco-Rius I, Mangas-Florencio L, Martins AF, Boehm-Sturm P, Zaitsev M, Zeiser R, Hövener JB, Reinheckel T, Groß O, Schmidt AB. Minute-Scale Repeated Metabolic Probing of Living Cells Enabled by Rapid Parahydrogen-Based Hyperpolarization. Angew Chem Int Ed Engl. 2026 Jul 10:e4855536. doi: 10.1002/anie.4855536. Epub ahead of print.
Matsuki E, Miyata M, Sato R, Gawron J, Suto M, Tamaki H, Fujiwara H, Ito A, Hishima T, Ishizawa Y, Sekiguchi E, Tobai T, Ushio S, Oravecz-Wilson K, Chen G, Tawara I, Ichikawa K, Watanabe M, Ishizawa K, Yokoyama H, Peltier D, Blazar B, Zeiser R, Reddy P, Toubai T. NLRP6 regulates donor T cell activation and acute graft-versus-host disease via ZAP-70-Erk pathway. Haematologica. 2026 Jul 2. doi: 10.3324/haematol.2025.289144. Epub ahead of print.
Ozyerli-Goknar E PhD, Nizamuddin S, Fetsch V, Biniossek ML, Hartmann A, Perner F, McGeehan GM, Armstrong SA, Zeiser R, Timmers HTM. Menin-MLL inhibitors enhance JUND activity in MLLr leukemic cells contributing to tumorigenesis and therapy resistance. Blood. 2026 Jun 29:blood.2025032363. doi: 10.1182/blood.2025032363. Epub ahead of print.
Fleischhauer K, Toffalori C, Cugnata F, Hofmann JA, Orofino G, Lorentino F, Ahci-Hanci M, Lange V, Müller CR, Kunadt D, Bornhäuser M, Sanz G, Soiffer R, Waterhouse M, Giaccone L, Ali H, Nachtkamp K, Bacigalupo A, Bonifazi F, Luznik L, Facchini L, Bramanti S, Nagler A, Saccardi R, Milano F, Zallio F, Pierini A, Mohty M, Flomenberg N, Takaori-Kondo A, Vey N, Teshima T, Kröger N, Laperche CM, Andreani M, Lupo Stanghellini MT, Peccatori J, Di Serio C, Kobbe G, Al Malki MM, Bruno B, Zeiser R, Lindsley RC, Sanz J, Beelen D, Stölzel F, Sauter J, Schmidt AH, Ciceri F, Vago L; HLALOSS Consortium. Donor Selection and Human Leukocyte Antigen Loss Leukemia Relapse After Hematopoietic Cell Transplantation. J Clin Oncol. 2026 Jun 25:JCO2600113. doi: 10.1200/JCO-26-00113. Epub ahead of print.
Rahbari M, Gris-Oliver A, Ramadori P, Aicher D, Sia D, Malek NP, Loomba R, Bataller R, Llovet JM, Heikenwälder M. The versatile interplay between steatotic liver disease and liver cancer. Nat Rev Cancer. 2026 Apr 14. doi: 10.1038/s41568-026-00918-y. Epub ahead of print.
Gawron J, Czech M, Rückert T, Holzmüller V, Andreev G, Burk AC, Hartmann A, Chatterjee S, Andrieux G, Marquard FE, Baur AS, Stell AV, Krausz M, Braun LM, Osswald N, Melchinger W, Wertheimer T, Proano-Vasco AI, Maas-Bauer K, Schmitt-Graeff A, Boerries M, Köhler N, Ayuk FA, Schell C, Quante M, Zeiser R. Gastrin for the treatment of acute graft-versus-host disease of the stomach. Blood. 2026 Apr 9;147(15):1763-1778. doi: 10.1182/blood.2025031080.

 

Highlighted by: Chakraverty R. GVHD fails the acid test. Blood. 2026 Apr 9;147(15):1660-1662.

Maas-Bauer K, Meyer T, Yücel M, Garofalaki M, Koßmann S, Biavasco F, Lysandrou M, Waterhouse M, Feuchtinger T, Pfeifer D, Ingelfinger F, Wertheimer T, Duyster J, Ahn JS, Soiffer RJ, Finke J, Wäsch R, Spyridonidis A, Kim DDH, Wehr C, Zeiser R. Mutational landscape changes of AML in patients relapsing after allogeneic hematopoietic cell transplantation. Bone Marrow Transplant. 2026 Apr 3. doi: . Epub ahead of print.
Braun LM, Naidoo J, Zeiser R. Immune-mediated side effects of cancer immunotherapies. Blood. 2026 Mar 9:blood.2025030059. doi: 10.1182/blood.2025030059. Epub ahead of print.
Chhatbar C, Sankowski R, Schulz M, Shimizu T, Schwabenland M, Staszewski O, Scheiwe C, Nessler S, Borst K, Dumas AA, Trost E, Berchtold D, Brandão W, Mossad O, Dalmau Gasull A, Frosch M, Erny D, Diebold M, Guffart E, Ternka K, Guranda M, Vinnakota JM, Friesen M, Ouk K, Waltl I, LaMorte M, Hammond TR, Di Liberto G, Vincenti I, Kreutzfeldt M, Mughrabi IT, Al-Abed Y, Blank T, Meyer-Luehmann M, Crow YJ, Hagen N, Ofengeim D, Zeiser R, Kettwig M, Gärtner J, Meisel A, Schwemmle M, Kalinke U, Beck J, Bengsch B, Thimme R, Butovsky O, Seredenina T, Ransohoff RM, Quintana FJ, Kierdorf K, Merkler D, Stadelmann C, Priller J, Prinz M. A transcriptomic microglia taxonomy across mouse and human pathologies. Nat Immunol. 2026 Mar 25:10.1038/s41590-026-02472-z. doi: 10.1038/s41590-026-02472-z. Epub ahead of print.
Heitmann JS, Maringer Y, Jung S, Wacker M, Hackenbruch C, Polster M, Marconato M, Nelde A, Bauer J, Zwick M, Baur AS, Metzger A, Krolla C, Andrieux G, Köhler N, Boerries M, Denk M, Zieschang L, Kammer C, Hoenisch-Gravel N, Richter M, Oezbek MT, Wirths S, Dengler A, Dubbelaar ML, Pumptow M, Martus P, Brüggemann M, Rammensee HG, Salih HR, Walz JS. Personalised multipeptide-based T-cell activator for chronic lymphocytic leukaemia: an open-label, single-centre, phase 1 study. Lancet Haematol. 2026 Feb;13(2):e74-e85. doi: 10.1016/S2352-3026(25)00323-0. Epub 2026 Jan 14. Erratum in: Lancet Haematol. 2026 Feb;13(2):e58. doi: 10.1016/S2352-3026(26)00012-8.
Li X, Lebeaupin C, Kadianaki A, Druelle-Cedano C, Vesper N, Rennert C, Huguet-Pradell J, Gomez Ramos B, Fan C, Piecyk RS, Zizmare L, Ramadori P, Li L, Frick L, Qiu M, Zhang C, Martins Nascentes Melo L, Ranvir VP, Shen P, Hanselmann J, Kosla J, Fernández-Vaquero M, Vucur M, Baskaran P, Bao X, Coleman OI, Tang Y, Cetin M, Chen Z, Jang I, Del Prete S, Rahbari M, Zhang P, Pham TV, Hou Y, Sun A, Gu L, Kim LC, Rothermel U, Heide D, Ali A, Gallage S, Talvard-Balland N, Piqué-Gili M, Gris-Oliver A, Bevilacqua A, Schlicker L, Duffey A, Unger K, Szydlowska M, Hetzer J, Odom DT, Machauer T, Bucci D, Sant P, Lee JH, Rösler J, Meckelmann SW, Schreck J, Murray S, Simon MC, Nahnsen S, Schulze A, Ho PC, Jugold M, Breuhahn K, Mallm JP, Schirmacher P, Roth S, Rahbari N, Tschaharganeh DF, Roessler S, Goeppert B, Bengsch B, Andrieux G, Boerries M, Malek NP, Prinz M, Weber A, Zeiser R, Tamayo P, Bronsert P, Kurowski K, Thimme R, Yuan D, Carretero R, Luedde T, Pinyol R, Hartmann FJ, Karin M, Tasdogan A, Trautwein C, Mall M, Hofmann M, Llovet JM, Haller D, Kaufman RJ, Heikenwälder M. Activated ATF6α is a hepatic tumour driver restricting immunosurveillance. Nature. 2026 Mar;651(8106):796-807. doi: 10.1038/s41586-025-10036-8. Epub 2026 Feb 4.
Fetsch V, Schwöbel L, Ozyerli-Goknar E, Stell AV, Punta M, Plenge T, Klaus T, Gupta MK, Andrieux G, Shoumariyeh K, Pfeiffer S, Corrales E, Schlenke L, Baniadam H, Brandl SM, Andreis M, Remen M, Hartmann A, Grueter K, Zwick M, Köhler N, Kuban M, Metzger E, Rummelt C, Duyster J, Boerries M, Hofmann M, Färber J, Braun LM, Zähringer A, Lübbert M, Toffalori C, Vago L, Heidel FH, Minguet S, Apostolova P, Feuchtinger T, Maas-Bauer K, Blaeschke F, Kühn MWM, Timmers HTM, Wertheimer T, Perner F, Zeiser R. Menin inhibition enhances graft-versus-leukemia effects by T-cell activation and endogenous retrovirus induction in AML. Blood. 2026 Jan 29;147(5):584-601. doi: 10.1182/blood.2025029712.

 

Highlighted by: Chakraverty R. Menin inhibitors: a 2-in-1 defense versus AML immune evasion. Blood (2026) 147 (5): 482–483.

Duque-Afonso J, Rummelt C, Förster K, Zeiser R, Mougiakakos D. BCMA-CD3 T-cell engager as salvage therapy for multirefractory primary immune thrombocytopenia. Lancet. 2026 Jan 23:S0140-6736(25)02515-2. doi: 10.1016/S0140-6736(25)02515-2. Epub ahead of print.